These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 33655255)
21. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients. Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775 [TBL] [Abstract][Full Text] [Related]
22. Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection. Ko SH; Radecki P; Belinky F; Bhiman JN; Meiring S; Kleynhans J; Amoako D; Guerra Canedo V; Lucas M; Kekana D; Martinson N; Lebina L; Everatt J; Tempia S; Bylund T; Rawi R; Kwong PD; Wolter N; von Gottberg A; Cohen C; Boritz EA bioRxiv; 2024 Jan; ():. PubMed ID: 38313289 [TBL] [Abstract][Full Text] [Related]
23. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]
24. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing. O'Shea KM; Schuler CF; Chen J; Troost JP; Wong PT; Chen K; O'Shea DR; Peng W; Gherasim C; Manthei DM; Valdez R; Baldwin JL; Baker JR Front Immunol; 2023; 14():1055429. PubMed ID: 36845123 [TBL] [Abstract][Full Text] [Related]
25. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic. Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105 [TBL] [Abstract][Full Text] [Related]
26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
27. Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses. Wen Y; Guo W; Min Y; Zhong K; Zhang X; Xing X; Tong Y; Pan Y; Hong W; Cai W; Yu L Front Immunol; 2023; 14():1093709. PubMed ID: 36798118 [TBL] [Abstract][Full Text] [Related]
28. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses. Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162 [TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants. Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis. McGrath ME; Xue Y; Dillen C; Oldfield L; Assad-Garcia N; Zaveri J; Singh N; Baracco L; Taylor LJ; Vashee S; Frieman MB Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2204717119. PubMed ID: 36040867 [TBL] [Abstract][Full Text] [Related]
31. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S Front Immunol; 2021; 12():613045. PubMed ID: 33841395 [TBL] [Abstract][Full Text] [Related]
32. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada. Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H Front Public Health; 2022; 10():915363. PubMed ID: 35859775 [TBL] [Abstract][Full Text] [Related]
33. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020. Zhang S; Ma P; Orzechowski M; Lemmer A; Rzasa K; Bagnall J; Barkho S; Chen M; He L; Neitupski R; Tran V; Ackerman R; Gath E; Bond A; Frongillo G; Cleland T; Golas A; Gaca A; Fitzgerald M; Kelly K; Hazegh K; Dumont L; Hoffman C; Homer M; Marks P; Woolley A; Wong S; Gomez J; Livny J; Hung D mBio; 2023 Apr; 14(2):e0352322. PubMed ID: 36786604 [TBL] [Abstract][Full Text] [Related]
34. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]